Novozymes Biopharma DK A/S
CVR 29603537 · Public limited company (A/S) · In voluntary liquidation
Novozymes Biopharma DK A/S is a Public limited company (A/S), founded on , based in Bagsværd. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. The company is no longer active (status: in voluntary liquidation). 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 29.7m and a net result of DKK 13.7m.
Company details
- CVR number
- 29603537
- Status
- In voluntary liquidation
- Company type
- Public limited company (A/S)
- Founded
- Address
- Krogshøjvej 36
2880 Bagsværd - Municipality
- Gladsaxe
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 612k
- Employees
- 0 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 20 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 88.4% |
| Current ratio | 865% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 8 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 17.7m | DKK 12.8m |
| Net profit | DKK 13.7m | DKK 11.5m |
| Equity | DKK 29.7m | DKK 23.0m |
| Total assets | DKK 33.6m | DKK 29.4m |
| Cash | DKK 1.5m | – |
| Short-term debt | DKK 3.9m | – |
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 154 | ||
| 1 Jan 2024 – 31 Dec 2024 | 170 | ||
| 1 Jan 2023 – 31 Dec 2023 | 173 | ||
| 1 Jan 2022 – 31 Dec 2022 | 157 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 180 | ||
| 1 Jan 2019 – 31 Dec 2019 | 176 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 152 | ||
| 1 Jan 2015 – 31 Dec 2015 | 151 | ||
| 1 Jan 2014 – 31 Dec 2014 | 153 | ||
| 1 Jan 2013 – 31 Dec 2013 | 182 | ||
| 1 Jan 2012 – 31 Dec 2012 | 149 | ||
| 1 Jan 2011 – 31 Dec 2011 | 152 | ||
| 1 Jan 2010 – 31 Dec 2010 | 149 | ||
| 1 Jan 2009 – 31 Dec 2009 | 151 | ||
| 1 Jan 2008 – 31 Dec 2008 | 116 | ||
| 1 Jan 2007 – 31 Dec 2007 | 148 | ||
| 29 May 2006 – 31 Dec 2006 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mikkel Viltoft | ||
| Board | Steen Riisgaard | ||
| Board | Per Artur Fredrik Månsson | ||
| Board | Niels Herman Münter | ||
| Board | Benny Dalgaard Loft | ||
| Board | Kristian Merser | ||
| Board | Thomas Videbæk | ||
| Board | Mikkel Viltoft | ||
| Board | Benny Dalgaard Loft | ||
| Board | Søren Knud Carlsen | ||
| Board | Thomas Videbæk | ||
| Board | Joseph Donald deBethizy | ||
| Board | Randi Camilla Kinch Jensen | ||
| Board | Gunnar Magnus Severus Modée Persson | ||
| Board | Tina Sejersgård Fanø | ||
| Board | Randi Camilla Kinch Jensen | ||
| Board | Mikkel Viltoft | ||
| Board | Lars Green | ||
| Board | Rainer Chapour Lehmann | ||
| Board | Lisbet Kragelund | ||
| Owner (100%) | NOVOZYMES A/S | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | NOVOZYMES A/S | Current |
The CEOs' other companies
Mikkel Viltoft – 6 other companies
- NOVOZYMES ADENIUM BIOTECH A/S Fusioneret
- NOVOZYMES BIOINDUSTRIAL A/S Active
- NOVOZYMES BIOINDUSTRIAL CHINA A/S Active
- NOVOZYMES BIOINDUSTRIAL HOLDING A/S Fusioneret
- Novonesis Plant Biosolutions A/S Active
- Novozymes Biotechnology ApS Fusioneret
Address history (2 moves)
| Krogshøjvej 36, 2880 Bagsværd | |
| Lottenborgvej 26, 2800 Kgs. Lyngby | |
| Krogshøjvej 36, 2880 Bagsværd |
Former names
| Novozymes Biopharma DK A/S | – now |
| Albumedix A/S | – |
| NOVOZYMES BIOPHARMA DK A/S | – |
| NOVOZYMES BIOTECHNOLOGY A/S | – |
Employees per year
Other companies at the same address
- NOVOZYMES A/S Active
- NOVOZYMES ADENIUM BIOTECH A/S Fusioneret
- NOVOZYMES BIOINDUSTRIAL A/S Active
- NOVOZYMES BIOINDUSTRIAL CHINA A/S Active
- NOVOZYMES BIOINDUSTRIAL HOLDING A/S Fusioneret
- NOVOZYMES BIOPOLYMER A/S Fusioneret
- NOVOZYMES BIOPOLYMER HOLDING A/S Fusioneret
- Novozymes Biotechnology ApS Fusioneret
Similar companies in Gladsaxe
- APEX PHARMA ApS Søborg
- Pierre Fabre Dermo-Cosmétique Nordic A/S Søborg
- MERCK A/S Søborg
- ALMIRALL ApS Søborg
- CONVATEC DENMARK A/S Søborg
- SPECIALBANDAGER.DK A/S Bagsværd
- MCNEIL DENMARK ApS Søborg
- TEVA DENMARK A/S Søborg
- CONTURA A/S Søborg
- MERCK LIFE SCIENCE A/S Søborg
- Hjerte112 A/S Søborg
- MEDIVIT ApS Søborg
Questions and answers about Novozymes Biopharma DK A/S
Has Novozymes Biopharma DK A/S gone bankrupt?
No, Novozymes Biopharma DK A/S is not registered as bankrupt in the CVR register. Its status is: in voluntary liquidation.
Who is the auditor of Novozymes Biopharma DK A/S?
Novozymes Biopharma DK A/S most recently used EY Godkendt Revisionspartnerselskab.
When was Novozymes Biopharma DK A/S founded?
Novozymes Biopharma DK A/S was founded on 29 May 2006.
What is the equity of Novozymes Biopharma DK A/S?
Equity was DKK 29.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.